This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Musk, OpenAI file trial briefs on key charitable trust dispute in US trial

( April 30, 2026, 21:21 GMT | Official Statement) -- MLex Summary: Elon Musk and OpenAI, and its executives Sam Altman and Greg Brockman filed written arguments with a federal judge over whether OpenAI and Altman "solicited" charitable donations from Musk after OpenAI was founded as a nonprofit in 2015. OpenAI and Altman's solicitation "falls squarely within the scope of the statute. As a party solicited to make donations that were accepted but then misused by the charity for unauthorized activity, Musk is empowered to vindicate his rights under California law," Musk said. The OpenAI defendants countered that "there is no legal or factual basis for Musk’s argument that a charitable trust was created under those provisions of California’s charitable solicitations statute. Accordingly, the jury should not be instructed regarding this alternative basis for Musk’s claim."See attached documents....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login